← All trials
NCT02078791
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2012
- Primary completion
- Sep 1, 2013
- Completion date
- Feb 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 66
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Rovira i Virgili UniversityLead sponsor
- Rovira i Virgili UniversityReponsible party - principal investigator
- Rovira i Virgili UniversityStudy director
- Catalan Institute of HealthCollaborator
- Universidad Nacional de Educación a DistanciaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.